Intech Biopharm

Intech Biopharm Share Count Growth

Year-over-Year Share Count Growth of Intech Biopharm (6461.TWO) as of Nov 17, 2026.

Share Count Growth

0.00

Last updated:

Year-over-Year Share Count Growth of Intech Biopharm is 2025 0.00 . Year-over-Year Share Count Growth of Intech Biopharm was 2024 0.00 . It decreases by % lower compared to the previous year.

The Intech Biopharm Share Count Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Share Count Growth
Date
Share Count Growth
Jan 1, 2018
0.00 TWD
Jan 1, 2019
0.00 TWD
Jan 1, 2020
0.00 TWD
Jan 1, 2021
0.00 TWD
Jan 1, 2022
0.00 TWD
Jan 1, 2023
0.00 TWD
Jan 1, 2024
0.00 TWD
Jan 1, 2025
0.00 TWD
The Intech Biopharm Share Count Growth history
YEARShare Count GrowthYoY
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intech Biopharm Stock analysis

What does Intech Biopharm do? Intech Biopharm Ltd is a pharmaceutical company based in Taipei City, Taiwan. The company went public on July 15, 2014, with the ticker symbol 6461.TWO and ISIN TW0006461007. It operates within the Health Care sector, specifically in the Pharmaceuticals industry. Intech Biopharm focuses on developing drugs for obstructive airway diseases, including bronchial asthma and chronic obstructive pulmonary disease. The company's primary products are respiratory drugs, notably the Duasma hexafluoroacetone (HFA) metered-dose inhalers (MDIs) and the Synvent HFA MDIs. These products are distributed both domestically within Taiwan and internationally. The company maintains a website at http://www.intechbiopharm.com/ for further information. Intech Biopharm Ltd is engaged in the research, development, and distribution of pharmaceutical products targeting respiratory conditions, with a focus on innovative inhaler technologies. The firm's operations are centered on addressing unmet medical needs in respiratory care through its specialized drug formulations. Intech Biopharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intech Biopharm stock

On Eulerpool you can find the complete historical development of Year-over-Year Share Count Growth Intech Biopharm since 2006 – with annual values, charts, and detailed analysis.

Share count growth measures the percentage change in shares outstanding. Negative growth indicates buybacks reducing dilution, positive growth signals dilution.

To evaluate Year-over-Year Share Count Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Share Count Growth.

Year-over-Year Share Count Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Share Count Growth's Intech Biopharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Intech Biopharm

All Key Metrics — Intech Biopharm